awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39576908-8F5985C4-3B13-44EA-B3BA-F8666BCC3F73
Q39576908-8F5985C4-3B13-44EA-B3BA-F8666BCC3F73
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39576908-8F5985C4-3B13-44EA-B3BA-F8666BCC3F73
Financial consequences of a payment-by-results scheme in Catalonia: gefitinib in advanced EGFR-mutation positive non-small-cell lung cancer.
P2860
Q39576908-8F5985C4-3B13-44EA-B3BA-F8666BCC3F73
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39576908-8F5985C4-3B13-44EA-B3BA-F8666BCC3F73
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
87bcb4455ca7bd84326aa00210ff3a83bb4f048f
P2860
Do the current performance-based schemes in Italy really work? "Success fee": a novel measure for cost-containment of drug expenditure.